These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
531 related items for PubMed ID: 23218024
1. Impact of ventricular assist device complications on posttransplant survival: an analysis of the United network of organ sharing database. Healy AH, Baird BC, Drakos SG, Stehlik J, Selzman CH. Ann Thorac Surg; 2013 Mar; 95(3):870-5. PubMed ID: 23218024 [Abstract] [Full Text] [Related]
4. Transplant registrants with implanted left ventricular assist devices have insufficient risk to justify elective organ procurement and transplantation network status 1A time. Dardas T, Mokadam NA, Pagani F, Aaronson K, Levy WC. J Am Coll Cardiol; 2012 Jul 03; 60(1):36-43. PubMed ID: 22541833 [Abstract] [Full Text] [Related]
5. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L. Ann Thorac Surg; 2008 Oct 03; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167 [Abstract] [Full Text] [Related]
16. The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation. Bull DA, Reid BB, Selzman CH, Mesley R, Drakos S, Clayson S, Stoddard G, Gilbert E, Stehlik J, Bader F, Kfoury A, Budge D, Eckels DD, Fuller A, Renlund D, Patel AN. J Thorac Cardiovasc Surg; 2010 Jul 03; 140(1):169-73. PubMed ID: 20451930 [Abstract] [Full Text] [Related]
17. Should patients 60 years and older undergo bridge to transplantation with continuous-flow left ventricular assist devices? Allen JG, Kilic A, Weiss ES, Arnaoutakis GJ, George TJ, Shah AS, Conte JV. Ann Thorac Surg; 2012 Dec 03; 94(6):2017-24. PubMed ID: 22858277 [Abstract] [Full Text] [Related]
18. The association of pretransplant HeartMate II left ventricular assist device placement and heart transplantation mortality. Donneyong M, Cheng A, Trivedi JR, Schumer E, McCants KC, Birks EJ, Slaughter MS. ASAIO J; 2014 Dec 03; 60(3):294-9. PubMed ID: 24614355 [Abstract] [Full Text] [Related]
19. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW. Circulation; 2007 Jul 31; 116(5):497-505. PubMed ID: 17638928 [Abstract] [Full Text] [Related]
20. The use of continuous milrinone therapy as bridge to transplant is safe in patients with short waiting times. Assad-Kottner C, Chen D, Jahanyar J, Cordova F, Summers N, Loebe M, Merla R, Youker K, Torre-Amione G. J Card Fail; 2008 Dec 31; 14(10):839-43. PubMed ID: 19041047 [Abstract] [Full Text] [Related] Page: [Next] [New Search]